-
May 1, 2008
Prozac may slow multiple sclerosis: study
The popular antidepressant Prozac may help slow multiple sclerosis,
according to a Dutch study showing that people who took the drug
had fewer of the brain lesions that are a hallmark of the incurable
disease.
-
April 30, 2008
Prozac Reduces Disease Activity in MS Patients
Small study finds antidepressant cut inflammation in relapsing
remitting illness
-
April 18, 2008
Mature Mouse Cells Reprogrammed to Stem Cell-Like State
Work could lead to better understanding of autoimmune diseases,
researchers say
-
April 17, 2008
Biogen says no new brain infections with Tysabri
Biogen Idec and its partner Elan Corp said on Tuesday no new cases
of a potentially deadly brain infection have been seen among
patients taking their Tysabri multiple sclerosis drug since it was
re-introduced in July 2006.
-
April 16, 2008
Pill Reduces Relapses in MS Patients
First oral drug could benefit many with the autoimmune disease,
researchers say
-
Most Early-Onset Dementia Not Alzheimer's
Other neurodegenerative, autoimmune diseases are more often cause,
study finds
-
March 7, 2008
Health Tip: Understanding Autoimmune Diseases
When the body begins to attack itself
-
February 27, 2008
Tysabri May Cause Liver Damage, Health Officials Say
MS drug also used to treat Crohn's disease can show injury in as
little as 6 days
-
February 18, 2008
New MS Drug Target Shows Promise
In mice, targeting blood coagulation pathway eased disease-linked
paralysis, researchers say
-
February 14, 2008
Cancer drug slows multiple sclerosis
Two infusions of the cancer drug Rituxan given 2 weeks apart slowed
the progression of multiple sclerosis for nearly 1 year,
researchers reported on Wednesday.
-
Cancer drug slows multiple sclerosis
Two infusions of the cancer drug Rituxan given 2 weeks apart slowed
the progression of multiple sclerosis for nearly 1 year,
researchers reported on Wednesday.
-
February 13, 2008
Cancer Drug Works Against MS in Early Trial
Promising results need to be replicated in larger study, experts
caution
-
Marijuana Use Among MS Patients Raises Risk for Cognitive, Mood
Problems
Study found slowed information-processing, increase in depression,
anxiety
-
February 6, 2008
Multiple Sclerosis Drug May Be Linked to Melanoma
Doctors report 2 cases of the deadly skin cancer developing in
patients taking Tysabri
-
January 16, 2008
DNA Analysis Could Help Customize Treatments for MS
Study suggests it could show who will respond best to interferon
beta treatments
-
January 14, 2008
MS Drug Tysabri Approved for Crohn's Disease
But the drug comes with serious risks, FDA notes
-
Study finds why some benefit from MS drug
Genetic factors may help reveal which multiple sclerosis patients
are likely to benefit from a widely used therapy and explain why
some are not helped, according to a report published on Monday.
-
December 11, 2007
Drug Combo With Antibiotic May Slow MS Progression
Interferon therapy plus doxycycline reduced number of brain
lesions, study finds
-
December 4, 2007
Hepatitis B vaccination not tied to MS in children
Vaccinating against hepatitis B virus (HBV) does not increase a
child's risk of developing multiple sclerosis (MS), according to a
study released Monday.
-
No Link Between Hepatitis B Shot, MS: Study
New research may help resolve ongoing debate
-
November 9, 2007
Scientists Find Way to Track Stem Cells in Brain
It could be a breakthrough for neurological research, experts say
-
October 19, 2007
Health Tip: Living With MS
Ways to help control the disease
-
October 15, 2007
Genzyme MS drug effective but monitoring required
Genzyme Corp said on Sunday that three-year data from a mid-stage
trial of its experimental multiple sclerosis drug showed it to be
very effective, but patients must be monitored on a monthly basis
to avoid a potentially deadly side effect.
-
Eye Scan May Help Diagnose, Treat MS
The inexpensive test could lead to new drugs, researchers add.
-
October 12, 2007
Familial MS May Be More Destructive
Brain scans reveal more damage compared to sporadic cases
-
October 11, 2007
No new cases of brain infection with Biogen drug
Biogen Idec Inc. and partner Elan said on Thursday that as of the
end of September there have been no new reported cases of a
potentially deadly brain infection in patients taking its multiple
sclerosis drug Tysabri.
-
October 10, 2007
Antibody Helps Repair MS Nerve Damage
Promising results in mice need to be repeated in humans, experts
say.
-
September 13, 2007
Stopping Tysabri May Worsen MS
Small study finds increase in disease-linked brain lesions.
-
August 14, 2007
New vaccine may help MS patients, study finds
An experimental vaccine against multiple sclerosis (MS) appears to
be safe and may produce beneficial changes in patients' brains and
immune systems, Canadian researchers reported on Monday.
-
August 3, 2007
Early interferon therapy may delay MS disability
Early treatment of multiple sclerosis (MS) patients with interferon
beta-1b therapy may help slow down the onset of disability,
according to a report in this week's issue of the UK medical
journal, The Lancet.
-
August 1, 2007
Device wakes man with severe brain injuries
A man with severe brain injuries who spent six years in a
near-vegetative state can now chew his food, watch a movie and talk
with family thanks to a brain pacemaker that may change the way
such patients are treated, U.S. researchers said on Wednesday.
-
July 30, 2007
Research identifies new genes linked with MS
After decades of dead ends, scientists have identified two genes
that may raise the risk of multiple sclerosis, lending insight into
the causes of the debilitating disease.
-
July 13, 2007
Walking robot offers clues to human movement
A walking robot that adapts to different terrain is helping
scientists understand how humans move and could one day lead to
improved treatment for spinal cord and other injuries, German
researchers said on Friday.
-
July 2, 2007
Clue seen to why MS disability worse for blacks
The abnormal immune response that leads to multiple sclerosis, or
MS, is stronger in African Americans than in whites with the
disease, new research indicates. This may partly explain why blacks
often experience greater disability.
-
June 28, 2007
Exercise training benefits stroke survivors
For stroke survivors who have completed rehab and are ambulatory,
exercise training is feasible and improves physical functioning and
aspects of mental health, an exploratory study conducted in the UK
shows.
-
June 27, 2007
Both parents contribute to MS risk in offspring
Contrary to the findings of a recent study, a new study suggests
that fathers with multiple sclerosis (MS) are no more likely than
mothers with MS to transmit the genetic risk of the disease to
their children.
-
June 21, 2007
Kids with MS become disabled at early age
People diagnosed with multiple sclerosis (MS) during childhood take
longer than older MS patients to reach the stage where they become
irreversibly disabled, but this point arrives at a younger age.
-
May 15, 2007
Testosterone gel may benefit men with MS
The findings from a small study suggest that a topical gel
containing the male hormone testosterone is safe and well tolerated
in men with multiple sclerosis and that it may reduce the nerve
damage that can occur with the disease.
-
May 11, 2007
Scientists ID Proteins Implicated in Huntington's Disease
Finding may spur treatments for fatal nervous system disorder
-
May 8, 2007
Pregnancy hormone may help with brain injury
In adult patients with traumatic brain injury, treatment with the
pregnancy-supporting hormone progesterone may improve outcomes --
especially in cases of moderate injury -- according to a report in
the Annals of Emergency Medicine.
-
May 3, 2007
No new brain infection cases with Biogen's Tysabri
Biogen Idec Inc. said on Thursday that there have been no new
confirmed cases of a potentially fatal brain infection associated
with its multiple sclerosis drug Tysabri, generically known as
natalizumab
-
May 1, 2007
Rituxan shows promise in multiple sclerosis trial
Genentech Inc. and Biogen Idec Inc. said on Tuesday their
blockbuster Rituxan drug for lymph cancer was highly effective
against multiple sclerosis in a small mid-stage trial.
-
Early Betaseron use helpful in MS patients: study
Early use of Bayer's multiple-sclerosis (MS) drug Betaseron can
significantly delay permanent disability for patients with MS, the
German drugs and chemicals company said on Tuesday.
-
CORRECTION: Doctors not prescribing meds that help MS
patients
Treatment with immune-modulating drugs can benefit people with
multiple sclerosis, or MS, but a study of physicians' prescribing
patterns shows that most MS patients do not get these medications.
-
Doctors not prescribing meds that help MS patients
Treatment with immune-modulating drugs can benefit people with
multiple sclerosis, or MS, but a study of physicians' prescribing
patterns shows that most MS patients do get these medications.
-
April 26, 2007
Many MS Patients Miss Out on Effective Drugs
They're not taking or being prescribed meds that ease side effects,
study finds
-
Mild brain injuries linked to sleep disorders
Experiencing a mild traumatic brain injury may increase the risk of
developing a sleep disorder, and a good portion of these appear to
be based on disturbances in the body's normal circadian rhythm,
according to the results of a new study.
-
April 3, 2007
Keeping up with the times key to successful aging
Whether it's listening to an iPod, playing video games or keeping
up with the news, staying in tune with the times may help people
live to 100.
-
March 30, 2007
Brain stimulation may curb MS spasticity
Magnetic stimulation of the brain (transcranial magnetic
stimulation or TMS) may help relieve "muscle spasticity" in people
with multiple sclerosis, Italian researchers have found.
-
Scientists plan China, HK, Taiwan stem cell trial
Scientists are preparing for a large clinical trial in 2008 which
aims to use stem cells to help 400 patients with spinal cord
injuries in Hong Kong, mainland China and Taiwan grow new cells and
nerve fibers.
-
March 8, 2007
Activity cuts seniors' disability risk
Staying physically active may ward off disability among healthy
older people, a new study shows.
-
Exercise slows decline in Alzheimer's patients
Nursing home residents with Alzheimer's disease who participate in
a moderate exercise program have a significantly slower
deterioration than those who receive routine medical care,
researchers have shown.
-
January 29, 2007
Study Yields Clues to Lincoln-Linked Nerve Disease
Gene defect that weakened cells may have affected the president.
-
December 15, 2006
Soy-Based Inhibitor Holds Promise as MS Treatment
Natural substance reduced nervous system inflammation in animal
study
-
December 1, 2006
Study Unearths Clues on How Body Absorbs Folate
Findings may yield test for infants, adults to prevent neurological
problems
font size
